Your browser doesn't support javascript.
Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment.
Yoon, Jin Gu; Yoo, Jin Sae; Lee, Jungmin; Hyun, Hak-Jun; Seong, Hye; Noh, Ji Yun; Cheong, Hee Jin; Kim, Woo Joo; Kim, Young Rong; Heo, Jung Yeon; Bae, Joon-Yong; Cui, Chunguang; Lee, Sohyun; Park, Man-Seong; Song, Joon Young.
  • Yoon JG; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
  • Yoo JS; Department of Infectious Diseases, Ajou University School of Medicine, Suwon, South Korea.
  • Lee J; Department of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea.
  • Hyun HJ; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
  • Seong H; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
  • Noh JY; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
  • Cheong HJ; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
  • Kim WJ; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
  • Kim YR; Department of Infectious Diseases, Ajou University School of Medicine, Suwon, South Korea.
  • Heo JY; Department of Infectious Diseases, Ajou University School of Medicine, Suwon, South Korea.
  • Bae JY; Department of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea.
  • Cui C; Department of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea.
  • Lee S; Department of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea.
  • Park MS; Department of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea. Electronic address: ms0392@korea.ac.kr.
  • Song JY; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea. Electronic address: infection@korea.ac.kr.
J Infect ; 84(6): 834-872, 2022 06.
Article in English | MEDLINE | ID: covidwho-1757560
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2022.03.022

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2022.03.022